PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 64 filers reported holding PROQR THRAPEUTICS N V in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,693,000 | -3.7% | 461,000 | +0.7% | 0.02% | -11.8% |
Q3 2021 | $3,833,000 | -61.9% | 457,900 | -69.9% | 0.02% | -63.8% |
Q1 2021 | $10,059,000 | +502850.0% | 1,521,800 | +1521700.0% | 0.05% | – |
Q2 2015 | $2,000 | -96.4% | 100 | -96.0% | 0.00% | – |
Q1 2015 | $55,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |